Innate Pharma to Host Virtual Investor Event to Highlight Progress Against Company Strategy

NEXT STORY
Brains Bioceutical Corp. completes a USD $31.9 Million Capital Raise with Lead Investor DSM Venturing
PREV STORY
RAPT Therapeutics Announces Pricing of Public Offering of Common Stock
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Metreleptin and Lipodystrophy Data Presented at the Annual Meeting of the Endocrine Society

VANCOUVER, British Columbia & CAMBRIDGE, Mass., April 04, 2017 (GLOBE NEWSWIRE) -- Novelion Therapeutics ...

author_avatar
NASDAQ Market News

Basilea shareholders approve all proposals of the board of directors at the annual general meeting

author_avatar
NASDAQ Market News

CytoDyn Reports Preliminary Results from First Five Patients in Phase 2 NASH Open Label Leronlimab Trial. Lower Fatty Deposits in All 5 Patients by as Much as 45% and Lower Fibrosis in 4 Patients by as Much as 10% Compared to Baseline.

author_avatar
NASDAQ Market News